Abstract:Chronic kidney disease (CKD) can be diagnosed by chronic deterioration in kidney function associated with renal parenchymal damage and may progress to end-stage renal disease (ESRD), [ 1 ] which has become a major public health concern. More than 800 million individuals are affected by CKD in 2017, and CKD was predicted to be the fifth leading cause of years of life lost. [ 2 , 3 ] CKD patients had higher mortality rates, [ 4 ] and CKD represents a major public health issue in Taiwan. Wen et al revealed that more than 10% of the Taiwanese population may be affected by CKD. [ 5 ] Comorbidities, such as cardiovascular disease (CVD) and congestive heart failure, not only exacerbate CKD progression but also impact the quality of life and mortality in CKD patients. [ 1 ] Common treatment options for ESRD patients include kidney transplantation and dialysis. [ 6 ] Despite advances in dialysis technology and cardiovascular therapies, cardiovascular-related mortality due to cardiac arrhythmias remains the largest cause of death among patients undergoing general dialysis. In ESRD patients treated with hemodialysis, the incidence of congestive heart failure had increased to 77.3% in 2021. [ 7 ] Given the high morbidity and mortality of these intertwined diseases, the use of hospice palliative care for patients with advanced CKD and CVD is critical to ensure that patients could make informed medical decisions and receive optimal treatment for their needs. Similar to CVD and congestive heart failure, the progression from pre-ESRD to ESRD is highly variable and can follow an unpredictable trajectory. [ 8 , 9 ] Consequently, it is important to understand the progression trajectory to properly initiate and integrate palliative care services, such as the management of patient symptoms and discussion of renal replacement therapy options, including dialysis and non-dialysis management for advanced CKD patients. [ 10 , 11 ] There are already numerous studies on the epidemiology and short-term survival of ESRD patients, [ 12–14 ] but the research on the long-term survival of non-cancer patients with advanced CKD is scarce. Machine learning (ML) has been applied successfully to different chronic diseases, such as chronic liver diseases, CVD, chronic obstructive pulmonary disease, and metabolic syndrome. [ 15–23 ] Furthermore, several studies in the past 2 years have utilized time-series ML techniques to predict the COVID-19 pandemic trend. [ 20 ] Previous studies also used unsupervised learning and network visualization of big data for chronic disease diagnoses. [ 24 ] Machine learning techniques were used in several research about renal problems such as CKD early detection in the EHR database or prediction for acute kidney injury. Several studies have been conducted on the use of artificial intelligence (AI) in ESRD and CKD. [ 20 , 25–29 ] However, these studies mostly focused on CKD prevention or identification. [ 21 , 30–33 ] For mortality prediction in ESRD patients, most studies have focused on populations with only kidney transplant therapy or hemodialysis. [ 34–36 ] Therefore, this study intends to construct a mortality prediction model with AI for pre-ESRD and ESRD patients.

#2277 Artificial Intelligence for predicting heart failure in chronic kidney disease: analysis of a 5000-patient cohort

Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality

Prediction of chronic kidney disease and its progression by artificial intelligence algorithms

Electrocardiography-based Artificial Intelligence Algorithms Aid in Prediction of Long-term Mortality After Kidney Transplantation

Predicting chronic kidney disease progression with artificial intelligence

Artificial intelligence in chronic kidney diseases: methodology and potential applications

Using a machine learning model to predict the development of acute kidney injury in patients with heart failure

A Machine Learning-Based Prediction Model for Acute Kidney Injury in Patients With Congestive Heart Failure

Predicting the Progression of Chronic Kidney Disease: A Systematic Review of Artificial Intelligence and Machine Learning Approaches

Machine Learning Models for the Prediction of Renal Failure in Chronic Kidney Disease: A Retrospective Cohort Study

Specific patterns and potential risk factors to predict 3-year risk of death among non-cancer patients with advanced chronic kidney disease by machine learning

Machine learning to predict end stage kidney disease in chronic kidney disease

Interpretable machine learning model for predicting long-term cardiovascular mortality risk in chronic kidney disease patients using SHAP explainers

MO431: Estimation of the Risk of Progression and Renal Substitution Treatment in Patients With Chronic Kidney Disease Using an Artificial Intelligence Model

The Prediction of In-Hospital Mortality in Chronic Kidney Disease Patients with Coronary Artery Disease Using Machine Learning Models

Machine Learning-Based Mortality Prediction in Chronic Kidney Disease among Heart Failure Patients: Insights and Outcomes from the Jordanian Heart Failure Registry

Machine learning model for cardiovascular disease prediction in patients with chronic kidney disease

Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study

Machine Learning Improves Upon Clinicians' Prediction of End Stage Kidney Disease

Enhancing End Stage Renal Disease Outcome Prediction: A Multi-Sourced Data-Driven Approach

Artificial Intelligence Enabled Prediction of Heart Failure Risk from Single-lead Electrocardiograms